Copper(II) Affects the Biochemical Behavior of Proinsulin C‑peptide by Forming Ternary Complexes with Serum Albumin

• Published in: Journal of the American Chemical Society 2023-08, Vol.145 (30), p.16726-16738
• Main Authors: San Juan, Jessica A., Chakarawet, Khetpakorn, He, Zhecheng, Fernandez, Rebeca L., Stevenson, Michael J., Harder, Nathaniel H. O., Janisse, Samuel E., Wang, Lee-Ping, Britt, R. David, Heffern, Marie C.
• Format: Article
• Language: English
• ISSN: 0002-7863; 1520-5126
• DOI: 10.1021/jacs.3c04599

Peptide hormones are essential signaling molecules with therapeutic importance. Identifying regulatory factors that drive their activity gives important insight into their mode of action and clinical development. In this work, we demonstrate the combined impact of Cu­(II) and the serum protein albumin on the activity of C-peptide, a 31-mer peptide derived from the same prohormone as insulin. C-peptide exhibits beneficial effects, particularly in diabetic patients, but its clinical use has been hampered by a lack of mechanistic understanding. We show that Cu­(II) mediates the formation of ternary complexes between albumin and C-peptide and that the resulting species depend on the order of addition. These ternary complexes notably alter peptide activity, showing differences from the peptide or Cu­(II)/peptide complexes alone in redox protection as well as in cellular internalization of the peptide. In standard clinical immunoassays for measuring C-peptide levels, the complexes inflate the quantitation of the peptide, suggesting that such adducts may affect biomarker quantitation. Altogether, our work points to the potential relevance of Cu­(II)-linked C-peptide/albumin complexes in the peptide’s mechanism of action and application as a biomarker.